AFMBX
Price
$35.32
Change
-$0.35 (-0.98%)
Updated
Feb 21 closing price
Net Assets
242.17B
RLEFX
Price
$35.30
Change
-$0.35 (-0.98%)
Updated
Feb 21 closing price
Net Assets
242.17B
Ad is loading...

AFMBX vs RLEFX

Header iconAFMBX vs RLEFX Comparison
Open Charts AFMBX vs RLEFXBanner chart's image
American Funds American Balanced F3
Price$35.32
Change-$0.35 (-0.98%)
VolumeN/A
Net Assets242.17B
American Funds American Balanced R5E
Price$35.30
Change-$0.35 (-0.98%)
VolumeN/A
Net Assets242.17B
AFMBX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AFMBX vs. RLEFX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFMBX is a Hold and RLEFX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
AFMBX (242B) and RLEFX (242B) have equal amount of cash in the bank . AFMBX pays higher dividends than RLEFX: AFMBX (2.55) vs RLEFX (2.42). AFMBX was incepted earlier than RLEFX: AFMBX (8 years) vs RLEFX (9 years). AFMBX (171.00) and RLEFX (171.00) have comparable annual turnover. RLEFX has a lower initial minimum investment than AFMBX: RLEFX (250) vs AFMBX (1000000). AFMBX (9.58) and RLEFX (9.42) have marching annual gain over last year. AFMBX (31.95) and RLEFX (31.16) have equivalent 5 years return.
AFMBXRLEFXAFMBX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years9 years-
Gain YTD2.9142.915100%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets242B242B100%
Annual Yield % from dividends2.552.42106%
Returns for 1 year9.589.42102%
Returns for 3 years18.4518.08102%
Returns for 5 years31.9531.16103%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARLO11.470.23
+2.05%
Arlo Technologies
DMAC6.51-0.10
-1.51%
DiaMedica Therapeutics
RCL234.26-9.63
-3.95%
Royal Caribbean Group
COEP10.52-0.51
-4.62%
Coeptis Therapeutics Holdings Inc
SYM24.47-1.62
-6.21%
Symbotic